Results 11 to 20 of about 263,067 (305)

Expert consensus on the precise classification and diagnosis of acute respiratory distress syndrome [PDF]

open access: yesZhongguo Linchuang Yixue
Acute respiratory distress syndrome (ARDS) is a common critical illness in clinical practice, with a high mortality rate. Given the limited traditional treatment options for ARDS and the high heterogeneity among patients, most clinical trials have failed
Expert Group for Precise Classification and Diagnosis of Acute Respiratory Distress Syndrome
doaj   +2 more sources

Acute respiratory distress syndrome [PDF]

open access: yesEuropean Respiratory Review, 2017
Since its first description, the acute respiratory distress syndrome (ARDS) has been acknowledged to be a major clinical problem in respiratory medicine. From July 2015 to July 2016 almost 300 indexed articles were published on ARDS.
Marco Confalonieri   +2 more
doaj   +2 more sources

Simultaneous intratracheal administration of surfactant and budesonide in the prevention of bronchopulmonary dysplasia in the treatment of respiratory distress syndrome in premature infants

open access: yes, 2023
Background: Premature birth is an important issue in developing and developed countries. The purpose of this study is to investigate the effect of budesonide and surfactant in the treatment of respiratory distress syndrome and the prevention of ...
Norouzi, Elahe   +4 more
core   +1 more source

Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality

open access: yesCritical Care Explorations, 2021
Objectives:. To investigate the differences in clinical course, ventilator mechanics, and outcomes of patients with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection compared with a historical cohort of acute respiratory
Alaa Abu Sayf, MD   +17 more
doaj   +1 more source

Surfactant function in neonates with respiratory distress syndrome [PDF]

open access: yes, 1998
The function of pulmonary surfactant of a group of 14 preterm neonates (birth weight 907 +/- 60 g) who suffered from severe respiratory distress syndrome (RDS) and who had received exogenous bovine lipid extracted surfactant on the first day of life was ...
Griese, Matthias, Westerburg, Bettina
core   +1 more source

Effect of Using Clinical Pathway on Nursing Care of Neonates with Respiratory Distress Syndrome [PDF]

open access: yesTanta Scientific Nursing Journal, 2017
Respiratory distress syndrome (RDS) considered one of the most serious disorders which leading to high morbidities and mortalities among neonates. It occurs when a neonate's lungs aren't fully developed and unable to gain enough oxygen.
Basma : Abdel Sadik, Samah Khalaf
doaj   +1 more source

The acute respiratory distress syndrome [PDF]

open access: yesJournal of Clinical Investigation, 2012
The acute respiratory distress syndrome (ARDS) is an important cause of acute respiratory failure that is often associated with multiple organ failure. Several clinical disorders can precipitate ARDS, including pneumonia, sepsis, aspiration of gastric contents, and major trauma. Physiologically, ARDS is characterized by increased permeability pulmonary
Matthay, Michael A   +2 more
openaire   +4 more sources

Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients [PDF]

open access: yes, 1993
Adult respiratory distress syndrome (ARDS) can develop as a complication of various disorders, including sepsis, but it has not been possible to identify which of the patients at risk will develop this serious disorder.
Moore, Frederick A.   +9 more
core   +1 more source

Individualized ventilatory management in patients with COVID-19-associated acute respiratory distress syndrome

open access: yesRespiratory Medicine Case Reports, 2021
Due to the coronavirus disease 2019 pandemic, the number of coronavirus disease 2019-associated acute respiratory distress syndrome is rapidly increasing.
Hiroki Taenaka   +6 more
doaj   +1 more source

Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol : a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome [PDF]

open access: yes, 2011
Background: The Acute Respiratory Distress Syndrome (ARDS) is a common cause of respiratory failure in critically ill patients. Experimental studies suggest that treatment with beta agonists may be helpful in ARDS.
McCabe Chris   +28 more
core   +1 more source

Home - About - Disclaimer - Privacy